Advertisement

Topics

CEL-SCI Announces That the NYSE MKT Approves Plan

09:40 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
CEL-SCI Corporation (NYSE MKT: CVM) announces that the NYSE MKT (the “Exchange”) has accepted the Company’s plan to bring itself into compliance with the Exchange's continued listing standards. The Company previou...

Other Sources for this Article

CEL-SCI Corporation
Gavin de Windt, 703-506-9460
www.cel-sci.com

NEXT ARTICLE

More From BioPortfolio on "CEL-SCI Announces That the NYSE MKT Approves Plan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...